Paradigm Biopharmaceuticals Limited (PBIGF)

PBIGF Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 9, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	94	78	60	186	154	362
Market Cap Growth	-33.96%	30.63%	-67.89%	20.20%	-57.33%	-25.94%
Enterprise Value	82	62	37	130	117	298
Last Close Price	0.23	0.22	0.19	0.63	0.67	1.69
PS Ratio	-	-	-	-	2829.64	23494.01
PB Ratio	6.76	5.61	3.60	5.20	5.30	6.17
P/TBV Ratio	6.89	5.72	4.09	5.50	5.70	6.41
EV/Sales Ratio	-	-	-	-	2142.53	19352.81
Debt / Equity Ratio	0	0	0.01	0.01	0.02	0.01
Net Debt / Equity Ratio	-0.79	-0.79	-0.71	-1.04	-0.92	-0.90
Net Debt / EBITDA Ratio	0.73	0.73	0.27	0.94	0.82	1.63
Net Debt / FCF Ratio	1.05	1.05	0.27	1.24	1.21	2.01
Asset Turnover	-	-	-	-	0.00	0
Quick Ratio	7.17	7.17	7.12	4.85	5.93	13.74
Current Ratio	7.46	7.46	7.51	4.89	6.02	13.98
Return on Equity (ROE)	-81.66%	-81.66%	-149.69%	-108.16%	-65.10%	-36.79%
Return on Assets (ROA)	-55.11%	-55.11%	-85.28%	-63.78%	-44.22%	-27.38%
Return on Capital Employed (ROCE)	-109.40%	-109.40%	-260.30%	-111.20%	-111.80%	-54.70%
Earnings Yield	-13.12%	-15.80%	-65.74%	-18.61%	-17.51%	-7.10%
FCF Yield	-	-13.46%	-73.81%	-16.20%	-14.37%	-7.24%
Buyback Yield / Dilution	-7.23%	-7.23%	-17.43%	-7.34%	-1.21%	-14.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.